About this Journal Submit a Manuscript Table of Contents
ISRN Dermatology
Volume 2012 (2012), Article ID 237802, 4 pages
http://dx.doi.org/10.5402/2012/237802
Research Article

Biochip Technology for the Serological Diagnosis of Bullous Pemphigoid

Unit of Dermatology, University of Padua, Via Battisti 206, 35121 Padua, Italy

Received 13 November 2012; Accepted 4 December 2012

Academic Editors: E. Alpsoy and E. Pasmatzi

Copyright © 2012 Haik Zarian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. H. Beutner, R. E. Jordon, and T. P. Chorzelski, “The immunopathology of pemphigus and bullous pemphigoid,” Journal of Investigative Dermatology, vol. 51, no. 2, pp. 63–80, 1968. View at Scopus
  2. J. R. Stanley, P. Hawley-Nelson, and S. H. Yuspa, “Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia,” Cell, vol. 24, no. 3, pp. 897–903, 1981. View at Scopus
  3. J. C. R. Jones, S. B. Hopkinson, and L. Goldfinger, “Structure and assembly of hemidesmosomes,” BioEssays, vol. 20, pp. 488–494, 1998.
  4. L. Borradori and A. Sonnenberg, “Structure and function of hemidesmosomes: more than simple adhesion complexes,” Journal of Investigative Dermatology, vol. 112, no. 4, pp. 411–418, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. L. M. T. Sterk, C. A. W. Geuijen, L. C. J. M. Oomen, J. Calafat, H. Janssen, and A. Sonnenberg, “The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin α6β4 and may regulate the spatial organization of hemidesmosomes,” Journal of Cell Biology, vol. 149, no. 4, pp. 969–982, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Zillikens, P. A. Rose, S. D. Balding et al., “Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies,” Journal of Investigative Dermatology, vol. 109, no. 4, pp. 573–579, 1997. View at Scopus
  7. G. Di Zenzo, S. Thoma-Uszynski, L. Fontao, et al., “Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid,” Clinical Immunology, vol. 128, pp. 415–426, 2008.
  8. M. Skaria, F. Jaunin, T. Hunziker et al., “IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230,” Journal of Investigative Dermatology, vol. 114, no. 5, pp. 998–1004, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Zillikens, “BP180 as the common autoantigen in blistering diseases with different clinical phenotypes,” Keio Journal of Medicine, vol. 51, no. 1, pp. 21–28, 2002. View at Scopus
  10. N. van Beek, K. Rentzsch, C. Probst et al., “Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy,” Orphanet Journal of Rare Diseases, vol. 7, article 49, 2012.
  11. E. H. Lee, Y. H. Kim, S. Kim, et al., “Usefulness of Enzyme-linked Immunosorbent Assay using recombinant BP180 and BP230 for serodiagnosis and monitoring disease activity of bullous pemphigoid,” Annals of Dermatology, vol. 24, pp. 45–55, 2012.
  12. M. Tampoia, A. Zucano, D. Villalta, A. Antico, and N. Bizzaro, “Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases,” Dermatology, vol. 225, pp. 37–44, 2012.